Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. WYFI
6. BTGO
7. NVDA
8. STUB
9. EAT
10. ARX

Go back to Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR)
(NASDAQ: KYMR) Delayed: 114.42 --0 (-0%)
Previous Close $114.42    52 Week High $ 
Open $114.42    52 Week Low $ 
Day High $114.42    P/E N/A 
Day Low $114.42    EPS $ 
Volume 1,552